Jun 05, 2019
Zinkan Enterprises Announces Its New Division, ChemREADY, a Water and Wastewater Solutions Group
Jun 03, 2019
AMPAC Fine Chemicals Announces New Addition To Their Executive Team
Jun 01, 2019
Daiichi Sankyo's Pexidartinib Demonstrated Further Improvement with Continued Treatment of Tenosynovial Giant Cell Tumor Patients in New Long-Term Analysis Presented at 2019 ASCO Annual Meeting
May 21, 2019
U.S. Chemical Production Gained In April
May 20, 2019
New Post-hoc Analysis Shows Adding UPTRAVI® (selexipag) Versus Placebo Improved Long-Term Clinical Outcomes Regardless of Time of Treatment Initiation, and Demonstrated an Even More Pronounced Treatment Effect When Initiated Early
Apr 24, 2019
U.S. Chemical Production Lower In March
Apr 22, 2019
World Ethyl Tertiary Butyl Ether (ETBE) Market Outlook and Forecasts Report 2019-2023 - ResearchAndMarkets.com
Apr 03, 2019
Global $60.72 Billion Electronic Chemicals and Materials Market Forecasts to 2023 - ResearchAndMarkets.com
Apr 02, 2019
Spectrum Chemical Partners with Macco Organiques to Provide Multicompendial Inorganic Salts for Biopharmaceutical Manufacturing
Mar 25, 2019
CutisPharma Announces Launch of FIRST®-Atenolol Unit-of-Use Prescription Compounding Kit for Oral Solution
Mar 21, 2019
China Interdye and China Textile Printing to take place in April in Shanghai
Mar 21, 2019
U.S. Chemical Production Declines In February
Mar 20, 2019
Xynomic Pharmaceuticals, Inc. Will Present at ASCO 2019 Annual Meeting, Will Sponsor an EU Investigator Meeting for Potentially Pivotal Kidney Cancer Trial, and Appoints Interim Chief Accounting Officer
Mar 18, 2019
The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025
Feb 25, 2019
Benzodiazepine Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Feb 22, 2019
U.S. Chemical Production Starts New Year with a Gain
Feb 14, 2019
AMPAC Fine Chemicals Expands And Focuses Executive Team
Feb 12, 2019
U.S. FDA Approves DARZALEX® (daratumumab) Split-Dosing Regimen
Feb 11, 2019
Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer
Feb 04, 2019
Cytomegalovirus Treatment Market Expected to Behold a CAGR of 6% Through 2018 - 2028